U.S. Stocks Finish Mixed Ahead of Big Tech Earnings Reports
Plus: McDonald\u2019s shares rise despite the company reporting lower quarterly sales. Shares of Abbott Laboratories decline after a jury finds the company failed to warn that its Similac formula for premature infants caused a bowel disease. J.R. Whalen reports.\n\n\n\nSign up for the WSJ's free What's News newsletter.\n\nLearn more about your ad choices. Visit megaphone.fm/adchoices